Quick Takeaways
- Opaleye Management Inc. filed SCHEDULE 13G for Larimar Therapeutics, Inc. Common Stock (LRMR).
- Disclosed ownership: 4.8%.
- Date of event: 29 Aug 2025.
Opaleye Management Inc. - 29 Aug 2025 SCHEDULE 13G Report for Larimar Therapeutics, Inc. Common Stock (LRMR)
- Filing Manager
- Opaleye Management Inc.
- Reporting Manager
- Opaleye Management, Inc.
- Symbol
- LRMR
- Shares outstanding
- 85,625,000 shares
- Disclosed Ownership
- 4,110,000 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G
- Filing time
- 29 Aug 2025, 16:05:23 UTC
- Date of event
- 29 Aug 2025
- Previous filing
- 16 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Opaleye Management Inc. disclosed 4.8% ownership in Larimar Therapeutics, Inc. Common Stock (LRMR) on 29 Aug 2025."
What Changed
- Previous schedule filing date: 16 Apr 2025.
- Current filing was accepted on 29 Aug 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Opaleye Management, Inc. | 4.8% | 4,110,000 | 0 | 4,110,000 | /s/ James Silverman | President | |
| Opaleye, L.P. | 4.8% | 4,110,000 | 0 | 4,110,000 | /s/ James Silverman | General Partner | |
| James Silverman | 4.8% | 4,110,000 | 0 | 4,110,000 | /s/ James Silverman | Individually |